Skip to content
Abierto
Menu

Award notice, total small business set-aside

Design and Engineering of VesiVax® HIV Immunogen Formulations”

75N93024C00018

National Institutes of Health, National Institutes of Health Niaid. Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology).

View on SAM.govMarkdown

Awarded

Molecular Express, Inc.

$1,999,866.00 on the award notice, June 25, 2024, contract 75N93024C00018

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

Recipient
Molecular Express, Inc.
UEI
R1JMHFESEKD5
CAGE
337D8
Vendor location
Rancho Dominguez, CA
Contract
75N93024C00018, definitive contract
Obligated
$1,999,866.00
Actions
2 between June 25, 2024 and June 2, 2026
Competition
Full and Open Competition After Exclusion of Sources, 2 offers received
Set-aside reported
Small Business Set Aside - Total
Described as
Design and Engineering of Vesivax Hiv Immunogen Formulations
Match
award number 75N93024C00018 equals the contract number; same awarding office 75N930 (high confidence)
Record
USAspending award page

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. July 1, 2024

    Award notice

    Design and Engineering of VesiVax® HIV Immunogen Formulations

    Awarded to MOLECULAR EXPRESS, Inc. Rancho Dominguez for $1,999,866. SAM.gov, notice f4ded7b6e2384590929e14b3ad6cc48c

  2. January 14, 2025

    Award notice

    Awarded to MOLECULAR EXPRESS, Inc. Rancho Dominguez for $1,999,866. SAM.gov, notice dfae6a23e87841cf8e02a4591b951645

Points of contact

Also open from this buyer